{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:03:11Z","timestamp":1757617391358,"version":"3.44.0"},"reference-count":20,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2025]]},"DOI":"10.70352\/scrj.cr.25-0264","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T22:08:10Z","timestamp":1757110090000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Liver Transplantation for Metabolic Dysfunction-Associated Steatotic Liver Disease after Pancreaticoduodenectomy"],"prefix":"10.70352","volume":"11","author":[{"given":"Takeshi","family":"Kano","sequence":"first","affiliation":[{"name":"Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryugen","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhisa","family":"Akamatsu","sequence":"additional","affiliation":[{"name":"Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiro","family":"Nishioka","sequence":"additional","affiliation":[{"name":"Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Mihara","sequence":"additional","affiliation":[{"name":"Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Ichida","sequence":"additional","affiliation":[{"name":"Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Takamoto","sequence":"additional","affiliation":[{"name":"Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikuni","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-740X","authenticated-orcid":false,"given":"Kiyoshi","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kato H, Isaji S, Azumi Y, et al. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci 2010; 17: 296\u2013304.","DOI":"10.1007\/s00534-009-0187-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Sobin LHGM, Wittekind C, ed. TNM classification of malignant tumours. 7 ed. 2009, Wiley-Blackwell: Oxford.","DOI":"10.1002\/9780471420194.tnmc26"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sim EH, Kwon JH, Kim SY, et al. Severe steatohepatitis with hepatic decompensation resulting from malnutrition after pancreaticoduodenectomy. Clin Mol Hepatol 2012; 18: 404\u201310.","DOI":"10.3350\/cmh.2012.18.4.404"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Jeon D, Park BH, Lee HC, et al. The impact of pylorus preservation on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy a historical cohort study. J Hepatobiliary Pancreat Sci 2022; 29: 863\u201373.","DOI":"10.1002\/jhbp.1150"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kang CM, Lee JH. Pathophysiology after pancreaticoduodenectomy. World J Gastroenterol 2015; 21: 5794\u2013804.","DOI":"10.3748\/wjg.v21.i19.5794"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Murata Y, Mizuno S, Kato H, et al. Nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: association of pancreatic exocrine deficiency and infection. Clin J Gastroenterol 2011; 4: 242\u20138.","DOI":"10.1007\/s12328-011-0226-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Satoh D, Yagi T, Nagasaka T, et al. CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy. World J Hepatol 2013; 5: 189\u201395.","DOI":"10.4254\/wjh.v5.i4.189"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Izumi H, Yoshii H, Fujino R, et al. Factors contributing to nonalcoholic fatty liver disease (NAFLD) and fat deposition after pancreaticoduodenectomy: a retrospective analysis. Ann Gastroenterol Surg 2023; 7: 793\u20139.","DOI":"10.1002\/ags3.12673"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tanaka N, Horiuchi A, Yokoyama T, et al. Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. J Gastroenterol 2011; 46: 758\u201368.","DOI":"10.1007\/s00535-011-0370-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Tanaka N, Takahashi S, Fang ZZ, et al. Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet. Biochim Biophys Acta Mol Cell Biol Lipids 2014; 1841: 1596\u2013607.","DOI":"10.1016\/j.bbalip.2014.08.015"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kato H, Kamei K, Suto H, et al. Incidence and risk factors of nonalcoholic fatty liver disease after total pancreatectomy: a first multicenter prospective study in Japan. J Hepatobiliary Pancreat Sci 2022; 29: 428\u201338.","DOI":"10.1002\/jhbp.1093"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Nagai M, Sho M, Satoi S, et al. Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 2014; 21: 186\u201392.","DOI":"10.1002\/jhbp.14"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ajmera V, Belt P, Wilson LA, et al. Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis. Clin Gastroenterol Hepatol 2018; 16: 1511\u20131520 e5.","DOI":"10.1016\/j.cgh.2018.01.026"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Sato R, Kishiwada M, Kuriyama N, et al. Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 2014; 21: 562\u201372.","DOI":"10.1002\/jhbp.115"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Patil DT, Yerian LM. Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation. Liver Transpl 2012; 18: 1147\u201353.","DOI":"10.1002\/lt.23499"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 2004; 4: 686\u201393.","DOI":"10.1111\/j.1600-6143.2004.00432.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Vallin M, Guillaud O, Boillot O, et al. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis. Liver Transpl 2014; 20: 1064\u201371.","DOI":"10.1002\/lt.23936"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Mehtani R, Rathi S. Recurrence of primary disease after adult liver transplant - risk factors, early diagnosis, management, and prevention. J Clin Exp Hepatol 2024; 14: 101432.","DOI":"10.1016\/j.jceh.2024.101432"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Stauffer JA, Steers JL, Bonatti H, et al. Liver transplantation and pancreatic resection: a single-center experience and a review of the literature. Liver Transpl 2009; 15: 1728\u201337.","DOI":"10.1002\/lt.21932"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) van Vilsteren FG, Baskin-Bey ES, Nagorney DM, et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: defining selection criteria to improve survival. Liver Transpl 2006; 12: 448\u201356.","DOI":"10.1002\/lt.20702"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.25-0264\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T04:18:39Z","timestamp":1757132319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.25-0264\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.25-0264","relation":{},"ISSN":["2198-7793"],"issn-type":[{"type":"electronic","value":"2198-7793"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"cr.25-0264"}}